Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation

Insilico Medicine Secures $110 Million Series E Financing to Advance AI-Driven Drug Discovery Innovation

CAMBRIDGE, Mass., March 13, 2025 /PRNewswire/ -- Insilico Medicine("Insilico"), a clinical-stage generative artificial intelligence (AI)-driven drug discovery company, announced today that it has successfully secured a $110 million Series E...

menu
menu